ReviewCureus2026
Recent Advances in the Diagnosis and Management of Cardiovascular Diseases: A Comprehensive Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases continue to represent a major global health challenge, driven by complex interactions between demographic transitions, lifestyle factors, and evolving clinical profiles. Over the past decade, substantial progress has been achieved in the diagnosis and management of cardiovascular disease, supported by technological innovation and a deeper understanding of underlying mechanisms. This review synthesizes recent advances in cardiovascular imaging, biomarker development, molecular diagnostics, interventional cardiology, pharmacological therapies, surgical techniques, digital health solutions, and preventive strategies. Emphasis is placed on how multimodal imaging, high-sensitivity biomarkers, genetic and omics-based approaches, and artificial intelligence have enhanced early detection, risk stratification, and personalized treatment planning. Contemporary interventional and surgical innovations are discussed in relation to improved safety, reduced invasiveness, and better patient outcomes. The review also highlights the growing role of digital health technologies and remote monitoring in chronic cardiovascular disease management, alongside preventive strategies targeting modifiable risk factors at both individual and population levels. Special attention is given to challenges in clinical integration, health equity, and applicability across diverse populations. By consolidating evidence across diagnostic and therapeutic domains, this review provides an integrated overview of current trends, clinical implications, and future directions, supporting informed decision-making and guiding the continued evolution of cardiovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.